4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001567619-23-004430
Chief Legal and HR Officer sold 2,248 shares at $19.30 ($43,386)
- Chief Legal and HR Officer acquired 1,875 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bizily Scott · Chief Legal and HR Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-03-01 | Exercise or conversion : show line 1 in the form | +1,875 | $6.49 | $12,169 | 4,357 | D |
| 2023-03-01 | Sale : show line 2 in the form | −2,248 | $19.30 | $43,386 | 2,109 | D |
| Open-market sales · 2,248 sh · avg $19.30 · $43,386 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-03-01 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −1,875 | 20,250 | D |
Loading xslF345X03/doc1.xml…